Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Entacapone (Comtan) and selegiline (Emsam, Zelapar) are both medications used to help manage symptoms of Parkinson's disease, particularly when carbidopa / levodopa starts to wear off. However, they belong to different medication classes. Entacapone is a catechol-O-methyltransferase (COMT) inhibitor, while selegiline is a monoamine oxidase type B (MAO-B) inhibitor. Entacapone is taken orally with each dose of carbidopa / levodopa, up to a maximum of 1,600 mg per day, and is available in both brand and generic forms. Selegiline, on the other hand, is available as tablets, capsules, and orally disintegrating tablets (ODTs), with dosing typically at 5 mg twice daily or 1.25 mg once daily for the ODT form. It also comes in patches. Selegiline is available as a lower-cost generic. Common side effects of entacapone include involuntary movements and nausea, while selegiline can cause nausea, dizziness, and changes in blood pressure. Entacapone has a few potential drug interactions, while selegiline has many interactions, including with antidepressants and certain foods. Both medications can cause sleepiness and impulsive behaviors, so it's important to be cautious with activities like driving.
Entacapone (Comtan)
Selegiline
Entacapone (Comtan)
Selegiline
Summary of Entacapone vs. Zelapar
Summary for COMT inhibitor
Prescription only
Entacapone (Comtan) is used for Parkinson's disease (PD) and helps relieve symptoms like shakiness and slowed movement. It's used along with the combination medication carbidopa/levodopa. Entacapone (Comtan) is a good option for people whose levodopa wears off before their next dose ("wearing-off" periods). But, this medication has to be taken every time you take carbidopa/levodopa for it to work properly. Some side effects include involuntary movements (dyskinesia) and nausea. Entacapone (Comtan) is available as a brand-name and generic medication.
Summary for MAO-B inhibitor
Prescription only
Selegiline helps relieve symptoms of Parkinson's disease in people who have "off" episodes as their carbidopa/levodopa medication starts to wear off. Selegiline is a type of monoamine oxidase inhibitor (MAOI), which is a drug class that has many drug interactions. Generic selegiline tablets and capsules are taken twice per day; the brand name for the pills, Eldepryl, is no longer available. Selegiline also comes as orally disintegrating tablets (ODTs) under the brand name Zelapar that are dissolved on the tongue once per day. Side effects include changes in blood pressure, nausea, and dizziness.
Indications of Entacapone vs. Zelapar
Indications for
•Relief of "wearing-off" symptoms in people with Parkinson's disease who are taking carbidopa/levodopa medications (e.g., Sinemet, Rytary)